SCHEMBL150560

SCHEMBL150560

COc1cc2ccnc(Cc3ccc(OC)c(OC)c3OC)c2cc1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.59
CASP3 P42574 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
SMN1; SMN2 Q16637 6/20 0.48
MAPT P10636 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
GAA P10253 1/20 0.48
PDE10A Q9Y233 9/20 0.47
PDE3A Q14432 6/20 0.47
PDE3B Q13370 5/20 0.47
CYP3A4 P08684 4/20 0.47
MAPK1 P28482 4/20 0.47
LMNA P02545 3/20 0.47
USP2 O75604 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HIF1A Q16665 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
TSHR P16473 2/20 0.47
PDE4A P27815 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149392 0.85 PDE10A (0.55) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL147885 0.80 PDE10A (0.75) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL10867414 0.79 RAB9A (0.58) RAB9ACASP3SENP6SMN1; SMN2MAPT
Dimethylamine SCHEMBL150792 0.78 PDE10A (0.72) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL129052 0.78 PDE10A (0.52) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL129950 0.76 PDE10A (0.58) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL2456041 0.76 RAB9A (0.97) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL147545 0.73 RAB9A (0.44) RAB9ACASP3SENP6SMN1; SMN2MAPT
SCHEMBL149447 0.73 PDE10A (0.73) RAB9ASMN1; SMN2MAPTTDP1PDE10A
SCHEMBL151891 0.72 PDE10A (0.55) RAB9ASMN1; SMN2MAPTTDP1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227966-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-05 US disclosed
US-20140315939-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-10-23 US disclosed
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed
WO-2010127307-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L RAB9A 1144/4885CASP3 83/4885SENP6 2656/4885
US-20140315939-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L RAB9A 964/4885CASP3 82/4885SENP6 2580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.